YBRAIN Information

Ybrain is South Korea's leading Brain-Computer Interface (BCI) platform company, dedicated to developing safe, reliable, and clinically validated neurotechnologies. As a pioneer in non-invasive medical BCIs, Ybrain has transformed mental healthcare with its diagnostic, monitoring, and electroceutical solutions for depression and neurological disorders. Today, our platforms are actively utilized by over 700 psychiatry clinics nationwide, building South Korea's largest medical-grade mental healthcare database with more than 1.4 million accumulated cases. Building upon our proven leadership in non-invasive therapeutics, Ybrain is advancing into high-resolution (1024ch+) bi-directional invasive BCIs. As a central facilitator of the K-BCI Alliance, we are building a collaborative ecosystem integrating advanced neurotechnology with precision surgical robotics, smart mobility, and healthcare services. Through enduring partnerships—including our collaboration with Hyundai Motor since 2020—we are developing AI-powered brain-robot interfaces designed to restore mobility and independence for paralyzed patients. Beyond technological innovation, Ybrain is committed to shaping the future of global neurotechnology by actively contributing to international BCI standardization committees (ISO/IEC JTC 1/SC 43) and national initiatives like the "K-Moonshot" project. At Ybrain, our ultimate mission is to empower patients with severe disabilities and neurological conditions to reclaim their daily lives and independence through trusted, cutting-edge neurotechnology.